Results

Total Results: 2,065 records

Showing results for "years".

41. Rapid Evidence Product_Nonemergent Percutaneous Coronary Intervention Versus Optimal Medical Treatment for Stable Ischemic Heart Disease: A Rapid Response Literature Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-evidence-heart-disease.pdf
    October 01, 2022 - from 2 to 11 years. … Mean age was 62.54 years, 80 percent of patients were male, and mean follow-up was 3.9 years. … 2.7 to 15 years. … , and follow-up ranged from in-hospital to 8 years. … , MI at 1 year or 4 years, or all-cause mortality at 1 year or 4 years.

42. App-D-Surv-Report-1-Noninvasive-Nonpharma 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
    January 01, 2021 - C Age: 65 vs. 61 vs. 65 years Female: 29% vs. 35% vs. 28% Race: - Caucasian: 41% vs. 33% vs. 37% Duration … B Age: 51 vs. 54 years Female: 94.7% vs. 100% Year since diagnosis: 8.16 vs. 8.98 years Baseline VAS … B Age: 51 vs. 50 years Female%: 48% vs. 47% Baseline VAS: 71 (14) vs. 67 (20.6) FIQ: 58.9 (10.9) … B Age: 63 vs. 63 years Female: 69% vs. 73% Race: NR Duration of symptoms (years): ≤1: 3% vs. 5% < 1 to … B Age: 54 vs. 54 years Female: 64% vs. 66% Race: NR Ethnicity: NR Duration of Symptoms: 15 vs. 14 years

43. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
    January 01, 2021 - C Age: 65 vs. 61 vs. 65 years Female: 29% vs. 35% vs. 28% Race: - Caucasian: 41% vs. 33% vs. 37% Duration … B Age: 51 vs. 54 years Female: 94.7% vs. 100% Year since diagnosis: 8.16 vs. 8.98 years Baseline VAS … B Age: 51 vs. 50 years Female%: 48% vs. 47% Baseline VAS: 71 (14) vs. 67 (20.6) FIQ: 58.9 (10.9) … B Age: 63 vs. 63 years Female: 69% vs. 73% Race: NR Duration of symptoms (years): ≤1: 3% vs. 5% < 1 to … B Age: 54 vs. 54 years Female: 64% vs. 66% Race: NR Ethnicity: NR Duration of Symptoms: 15 vs. 14 years

44. Systematic Review on Acute Treatments for Episodic Migraine: Surveillance Report 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
    June 01, 2022 - )" or "young adult (19 to 24 years)" or "adult (19 to 44 years)" or "young adult and adult (19-24 and … 19-44)" or "middle age (45 to 64 years)" or "middle aged (45 plus years)" or "all aged (65 and over … > or school child <7 to 12 years> or adolescent <13 to 17 years>) [Limit not valid in APA PsycInfo, … (12.5%), 31- 40 years (52.5%), >40 (35%) years, 50% female RCT in Iran, 10/2017 to 11/2018 ED … (22.5%), 31- 40 years (42.5%), >40 (35%) years, 50% female Sakai, 202113 RCT in Japan, 05/30/

45. Appendix Table B-3. Observational Studies of Masks in Healthcare Settings (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-3-version-1.xlsx
    February 01, 2020 - Study Design Study Dates Geographic Setting Clinical Setting Inclusion Criteria Sample Size Age (mean, years … HCW cases with SARS-CoV-1 seropositivity 91 cases and 657 controls Mean age not reported; 34.9% <26 years … old, 54.2% 26–40 years old, 10.8% >50 years old 76% 31.5% doctor 49.2% nurse 7.3% health attendant 5.0% … old; 33% 30–39 years old; 43% 40–50 years old 60% 13% doctor 26% nurse 54% other HCW 33% relative of … ; 38% age 30–39 years 77% 38% physician 62% nurse SARS-1 Not applicable Unadjusted OR (95% CI) Mask

46. Woolf_ECCS2012 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/woolf_eccs2012.pdf
    January 01, 2012 -  2009 • 2002 o B: Mammography, with or without clinical breast examination (CBE), every 1 to 2 years … Teaching/performing routine breast  self-­‐examination (BSE) • 2009 o B: Mammography every 1 to 2 years … for women age 50 to 74 o C: Mammography every 1 to 2 years for women age 40 to 49 o I: Mammography … Preventive Services Task Force] recommends against routine screening mammography in women aged 40 to 49 years … The decision to start regular, biennial screening mammography before the age of 50 years should be an

47. App-D-Surv-Report-3-Noninvasive-Nonpharma 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
    January 01, 2022 - C Age: 65 vs. 61 vs. 65 years Female: 29% vs. 35% vs. 28% Race: - Caucasian: 41% vs. 33% vs. 37% Duration … B Age: 51 vs. 54 years Female: 94.7% vs. 100% Year since diagnosis: 8.16 vs. 8.98 years Baseline VAS … B Age: 51 vs. 50 years Female%: 48% vs. 47% Baseline VAS: 71 (14) vs. 67 (20.6) FIQ: 58.9 (10.9) … B Age: 63 vs. 63 years Female: 69% vs. 73% Race: NR Duration of symptoms (years): ≤1: 3% vs. 5% < 1 to … B Age: 54 vs. 54 years Female: 64% vs. 66% Race: NR Ethnicity: NR Duration of Symptoms: 15 vs. 14 years

48. Executive Summary_Comparative Effectiveness Review No. 259: Partial Breast Irradiation for Breast Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-259-partial-breast-irradiation-executive-summary.pdf
    January 01, 2023 - terms of ipsilateral breast recurrence (IBR), overall survival, and cancer-free survival at 5 and 10 years … WBI, intraoperative radiotherapy (IORT) was associated with a higher IBR rate at 5, 10, and over 10 years … IMRT compared with WBI showed no difference in IBR and overall survival at 5 and 10 years (low SOE) … and better patient-rated cosmesis at 10 years (low SOE). … IORT compared with WBI showed a higher IBR rate with IORT at 5, 10, and over 10 years, in contrast to

49. Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nomination-apbi-breast-cancer.pdf
    April 01, 2017 - Include age greater than or equal to 50 years in the “suitable” group (moderate quality of evidence [ … Retain patients with age younger than 40 years or those who are 40 to 49 years without meeting other … In addition, there were no differences in toxicity through 5 years. … of age was 7.5%, and for patients ≥50 years was 1.1% (P = .030). … ELIOT has a median of 5.8 years follow up (n =1305).

50. Prostate-Cancer-Therapies-Update Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_executive.pdf
    December 01, 2014 - Favors WW at 2 years Medium Inconsistent Direct Imprecise Insufficient RP vs. … age category but not in the 65 years or older category. … of age, but not among men 70 years of age or younger. … design and 10 years in the updated design. … Low risk prostate cancer in men >/= 70 years old: to treat or not to treat.

51. App-D-Opioid-Chronic-Pain-Surveill-Report-1 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
    September 30, 2015 - Inclusion: Adults aged 18-64 years with post-surgical, non-cancer back pain; addiction to prescription … Oral methadone (30 to 60 mg daily) (9 assigned, 6 f/u) Overall sample Mean age: 41 years Female sex: … B Mean (SD) age, years: 64.9 (12.5) vs. 60.8 (9.7) Female: 20% vs. 45% White: NR Black: NR Hispanic: … B (events/total person-years); adjusted Incidence Rate Ratio (aIRR): Overdose: 3241/22097 vs. 11433/ … B (unmatched sample) Mean age (SD): 55.6 (13.22) vs. 58.2 (12.82) years Female sex: 9.88% vs. 9.49%

52. Noninvasive Treatments for Low Back Pain: A Summary of the Research for Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_consumer.pdf
    November 01, 2016 - - LowBackPain_consumer - Last mod on: 15-Nov-2016, 11:04 Archived: This report is greater than 3 years … 3.7c - LowBackPain_consumer - Last mod on: 15-Nov-2016, 11:04 Archived: This report is greater than 3 years … 3.7c- LowBackPain_consumer - Last mod on: 15-Nov-2016, 11:04 Archived: This report is greater than 3 years … 3.7c- LowBackPain_consumer - Last mod on: 15-Nov-2016, 11:04 Archived: This report is greater than 3 years … Archived: This report is greater than 3 years old.

53. Disposition of Comments for CER 166 Calcineurin Inhibitors (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/calcineurin-inhibitor_disposition-comments.pdf
    March 15, 2016 - displayproduct&productid=2193 Published Online: March 15, 2016 Archived: This report is greater than 3 years … displayproduct&productid=2193 Published Online: March 15, 2016 2 Archived: This report is greater than 3 years … of studies in this review were conducted We agree that clinical practice has changed in recent years … risk factors, as well as the kidney, itself.5 6 The accumulation of additional evidence in recent years … to research gaps, the need for well designed studies that have clinically meaningful outcomes at 5 years

54. Research Protocol: Disparities Within Serious Mental Illness (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-disparities_research-protocol.pdf
    July 01, 2015 - www.effectivehealthcare.ahrq.gov Published online: July 1, 2015 Archived: This report is greater than 3 years … Archived: This report is greater than 3 years old. … 380410 #13 Search (#11 AND #12) 1530 #16 Search (#11 AND #12) Filters: Humans; English; Adult: 19+ years … 1163 #17 Search (#11 AND #12) Filters: Systematic Reviews; Humans; English; Adult: 19+ years 28 … experiencing a mental health care disparity based on race, ethnicity, economic All GQs § <18 years

55. Executive Summary: Pain Management Interventions for Hip Fracture (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer30_hip-fracture-pain-executive-summary_20110517.pdf
    May 01, 2011 - The mean age of study participants ranged from 59.2 to 86.3 years. … The mean age ranged from 77.2 to 78.5 years; most patients were female. … The mean age of participants ranged from 70 to 86 years; most were female. … The mean age ranged from 76.8 to 86.3 years; most were female. … No. 11­EHC022­1 May 2011 Archived: This report is greater than 3 years old.

56. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-cough_research-protocol.pdf
    October 22, 2012 - In adults and adolescents (≥14 years of age) and children (<14 years of age), what is the comparative … In adults and adolescents (≥14 years of age) and children (<14 years of age), what are the comparative … of age) and children (< 14 years of age) presenting with cough. … ) • KQ 2: Adults and adolescents (≥ 14 years of age) and children (< 14 years of age) o With unexplained … o Subgroups of potential interest include:  Age (the elderly [over 65 years] children under 6 years

57. CER 173 Executive Summary: Diabetes Medications for Adults With Type 2 Diabetes: An Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_executive.pdf
    January 01, 2015 - Archived: This report is greater than 3 years old. … Archived: This report is greater than 3 years old. … Archived: This report is greater than 3 years old. … at least 2 years. … There was only one long-term trial lasting 4 years (the rest, less than 2 years) and only a few observational

58. Geographic Variation in Carotid Endarterectomy and Carotid Stenting Among Medicare Beneficiaries, 2003-2006 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cardiology-health-outcomes_research.pdf
    July 01, 2010 - per 1000 person-years in 2005 and 2006. … in Beaumont, Texas) and the lowest rate (0.82 per 1000 person- years in Honolulu, Hawaii). … in Beaumont, Texas, to 0.79 per 1000 person-years in Honolulu, Hawaii. … Across HRRs, the rates of carotid stenting ranged from 0.07 to 2.73 per 1000 person-years. … in 2003 to 2.7 per 1000 person-years in 2006.

59. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
    September 18, 2012 - – 26 years Influenza (inactivated) 6 months and older Influenza (live attenuated) 2 years and older … IPV (inactivated polio vaccine) 6 weeks and older MCV (meningococcal conjugate vaccine) 2 years and … ) 7 years and older Varicella 12 months and older Table 2. … and younger Influenza (inactivated) All adults Influenza (live attenuated) All adults 49 years and … vaccine Adults 64 years and younger with certain conditions, and all adults 65 years and older

60. Disposition of Comments for CER 172 Clostridium Difficile Diagnosis Prevention Treatment (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/c-difficile-update_disposition-comments.pdf
    March 29, 2016 - displayproduct&productid=2208 Published Online: March 29, 2016 Archived: This report is greater than 3 years … noted in the results section, evidence that studies documented sustained practices over several years … discuss them as it is likely that there will be additional information coming out in the next few years … One of the highest risk populations for CDI are people >65 years of age that are hospitalized and on … experts involved in that process have been aware of the inferiority of metronidazole for several years